Pharmaceutical Biotechnology

The Master's programme in Pharmaceutical Biotechnology has a standard period of study of four semesters. The first three semesters provide in-depth, scientifically oriented training in biotechnological core areas such as genetic engineering, enzyme technology, recombinant products, low-molecular active pharmaceutical ingredients and molecular medicine. Application-oriented teaching content is taught in engineering subjects such as bioprocess engineering, bioprocess development, cell culture technology and bioprocess control.

In the third semester, you also have the opportunity to specialise in elective modules based on your individual interests. In the fourth semester, you will write your Master's thesis. The aim is the independent scientific treatment of a topic in basic or applied research. The Master's thesis is usually written in a company or in a university-internal/external research institution and is supervised by professors from the Department of Medical Technology and Biotechnology.